https://www.civilizationventures.com/
[](https://assets-global.website-files.com/641d7b661f0152a85c086c76/64e3a8c6c86b64529cf6a312_Civilization Ventures_Montage3_V2 (1)-transcode.mp4)
Civilization launches with a $1M pilot fund to back innovators in genomics + diagnostics, digital health and synthetic biology (including gene + cell therapies).
Rocket Pharma lists on Nasdaq, and a unicorn is born. Rocket has multiple first-in-class gene therapies in clinical trials to cure devastating inherited diseases.
Singular Bio is acquired by Invitae to help increase access to accurate genetic screening in early pregnancy.